Eamon Javers joined CNBC in June 2010 as a Washington reporter based at the bureau in the nation's capital. He appears on CNBC's Business Day programming.
Previously, Javers was a White House reporter for Politico, where he covered the intersection of Wall Street and Washington. He conducted investigations of the administration's financial bailouts and economic stimulus efforts, broke news about the presidency of Barack Obama and authored trend stories on Washington.
Prior to joining Politico, Javers was a Washington correspondent for BusinessWeek magazine writing extensively about Washington lobbying, including the Jack Abramoff scandal and unearthed previously unknown incidents of corporate espionage. He also was an on-air correspondent for CNBC, where he covered the intersection of business and politics. Javers' articles have appeared in Fortune, Money, Congressional Quarterly and Slate.com. He began his career at The Hill, a weekly newspaper (and website) covering Congress.
Javers is author of the book "Broker, Trader, Lawyer, Spy: The Secret World of Corporate Espionage," which revealed a never-before-reported CIA policy allowing active-duty officers to moonlight in the private sector.
He has appeared as an analyst on each of the major broadcast networks, all of the major cable television news networks, "News Hour with Jim Lehrer" on PBS, the BBC and National Public Radio. He also is a regular panelist on "Washington Week with Gwen Ifill" on PBS.
In 2014, Javers was named a finalist in the Gerald Loeb Awards explanatory category for his coverage of how market-moving financial data is released. In 2006, Javers received an Award of Distinction in investigative journalism from the Medill School of Journalism. He graduated from Colgate University in Hamilton, N.Y.
Follow Eamon Javers on Twitter @EamonJavers.
CNBC's Eamon Javers breaks down details of President Obama's $4.15 trillion budget proposal.
CNBC's Eamon Javers reflects on the highlights of the Democratic debate between Hillary Clinton and Bernie Sanders, where Sanders said "not one of the executives on Wall Street has been charged with anything, after paying, in this case of Goldman Sachs, a $5 billion fine but no criminal record." Jonathan Bush, athenahealth CEO, provides perspective.
CNBC's Eamon Javers reports on government involvement in drug prices.
The House Oversight Committee wants Turing Pharmaceuticals founder Martin Shkreli to testify on the issue of raising drug prices, reports CNBC's Eamon Javers.